Cargando…
How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Clinical Oncology
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477927/ https://www.ncbi.nlm.nih.gov/pubmed/27507875 http://dx.doi.org/10.1200/JCO.2016.67.2055 |
| _version_ | 1783244869703041024 |
|---|---|
| author | Hasegawa, Takahiro Uno, Hajime Wei, Lee-Jen |
| author_facet | Hasegawa, Takahiro Uno, Hajime Wei, Lee-Jen |
| author_sort | Hasegawa, Takahiro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5477927 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | American Society of Clinical Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54779272017-06-29 How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? Hasegawa, Takahiro Uno, Hajime Wei, Lee-Jen J Clin Oncol Correspondence American Society of Clinical Oncology 2016-11-01 2016-08-08 /pmc/articles/PMC5477927/ /pubmed/27507875 http://dx.doi.org/10.1200/JCO.2016.67.2055 Text en © 2016 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Correspondence Hasegawa, Takahiro Uno, Hajime Wei, Lee-Jen How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? |
| title | How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? |
| title_full | How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? |
| title_fullStr | How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? |
| title_full_unstemmed | How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? |
| title_short | How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? |
| title_sort | how to summarize the safety profile of epoetin alfa versus best standard of care in anemic patients with metastatic breast cancer receiving standard chemotherapy? |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477927/ https://www.ncbi.nlm.nih.gov/pubmed/27507875 http://dx.doi.org/10.1200/JCO.2016.67.2055 |
| work_keys_str_mv | AT hasegawatakahiro howtosummarizethesafetyprofileofepoetinalfaversusbeststandardofcareinanemicpatientswithmetastaticbreastcancerreceivingstandardchemotherapy AT unohajime howtosummarizethesafetyprofileofepoetinalfaversusbeststandardofcareinanemicpatientswithmetastaticbreastcancerreceivingstandardchemotherapy AT weileejen howtosummarizethesafetyprofileofepoetinalfaversusbeststandardofcareinanemicpatientswithmetastaticbreastcancerreceivingstandardchemotherapy |